Arkolith/Insider Trading/BNTC/Form 4

Averill Master Fund, Ltd.

Director, 10% OwnerBenitec Biopharma Inc. (BNTC) · full profile →Form 4 · filed Nov 21, 2024
Net Buying
Open-Market Buys
$417K
Open-Market Sells
$0
Net Open-Market Flow
$417K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 20, 2024Buy(P)3K$10.22$31K950K
Nov 20, 2024Buy(P)24K$10.22$249K7.9M
Nov 19, 2024Buy(P)2K$9.73$15K947K
Nov 19, 2024Buy(P)12K$9.73$121K7.9M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899140-24-001299) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML